INSPIREMD INC. - COMMON STOCK

InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025

12 ديسمبر 2024 06:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)

09 ديسمبر 2024 06:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors

25 نوفمبر 2024 15:05:00 بحسب Nasdaq GlobeNewswire

InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update

12 نوفمبر 2024 06:00:01 بحسب Nasdaq GlobeNewswire

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

08 نوفمبر 2024 16:30:03 بحسب Nasdaq GlobeNewswire

InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th

04 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System

15 أكتوبر 2024 06:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System

07 أكتوبر 2024 06:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System

16 سبتمبر 2024 06:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update

06 أغسطس 2024 07:09:23 بحسب Nasdaq GlobeNewswire

InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment

05 أغسطس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

InspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, August 6th

30 يوليو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million

01 يوليو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024  

28 مايو 2024 07:53:00 بحسب Nasdaq GlobeNewswire

InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update

14 مايو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th

07 مايو 2024 06:00:01 بحسب Nasdaq GlobeNewswire

InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

03 أبريل 2024 07:59:14 بحسب Nasdaq GlobeNewswire

InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024

26 مارس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

06 مارس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6th

28 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire